Myricetin served as antagonist for negatively regulate MRGPRX2 mediated pseudo-allergic reactions through CD300f/SHP1/SHP2 phosphorylation.
发布时间：2025-04-30
点击次数：
- 发布时间：
- 2025-04-30
- 论文名称：
- Myricetin served as antagonist for negatively regulate MRGPRX2 mediated pseudo-allergic reactions through CD300f/SHP1/SHP2 phosphorylation.
- 发表刊物：
- International Immunopharmacology
- 合写作者：
- Baowen Dang, Shiting Hu, Yonghui Zhang, Yihan Huang, Tao Zhang*, Hongli An*
- 卷号：
- 118
- 页面范围：
- 110034
- 是否译文：
- 否
- 发表时间：
- 2023-05-01
- 上一条：Alpha-linolenic acid improves nasal mucosa epithelial barrier function in allergic rhinitis by arresting CD4+ T cell differentiation via IL-4Ralpha-JAK2-STAT3 pathway.
- 下一条：A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: Applications of MassARRAY DNA mass spectrometry.